Joel D. Becker
Previously Joel lead the $400M+ Cardiac Rhythm Management and Neuromodulation business as President for Integer Holdings LLC, a $1.2B publicly traded medical device contract development and manufacturing company, where he oversaw commercial execution with a focus on operational efficiencies and margin control. He also served as the President of the Americas Division for St. Jude Medical Inc., a $5.5B global medical device leader. In this role Joel lead the $3B commercial organizations for the electrophysiology, cardiology, structural heart, cardiac rhythm management and neuromodulation businesses in the Americas. In addition to a number of other leadership roles at St. Jude Medical, Joel also served as one of the founding members of the Atrial Fibrillation Division management team which he helped lead and grow to more than $700M in revenue.
Joel holds a Masters in Business Administration degree from the Carlson School of Management at the University of Minnesota.
Martha Morrell, MD
Kelley Nicholas has served as our Vice President of Sales since May 2023. Ms. Nicholas previously served as the Global Vice President of Marketing and Commercial Operations at Hologic, a medical device company, from June 2021-February 2023, where she was responsible for leading all functions of marketing, commercial operations and training, professional education, and communications for the Breast and Skeletal Health Division. In this role Ms. Nicholas led the development of the 5-year business strategic plan and implementation of commercial strategies to drive growth and market expansion in new and existing businesses globally. From 2020-2021, Ms. Nicholas served as the Global Vice President of Commercial for Thermo Fisher Scientific, a medical device company, where she was responsible for leading a global commercial team and led the re-design of the go-to-market strategy. Prior to that, from 2014-2020, Ms. Nicholas served in sales leadership roles at Medtronic across various business units, inclusive of neurosurgery, cardiac and vascular surgery, and diabetes. From 2008-2014, Ms. Nicholas served in roles of increasing responsibility in sales leadership at Baxter, a medical device company, in their Biosurgery Business Unit. Mrs. Nicholas earned her B.S. in Health Science / Physical Therapy from the University of Missouri, Columbia, and her MBA from Washington University in St. Louis.
Dylan St. John
Timothy Proulx has served as our Vice President, Product Development since June 2021. Prior to joining Neuropace, Mr. Proulx served as Sr. Director Engineering with Neurolutions, a medical device company, where he led development of a brain-computer interface (BCI) rehabilitation device for chronic stroke. From 2017 to 2019, Mr. Proulx served as Vice President R&D at Sonitus Technologies, a communications company in the industrial and military markets. Prior to that, from 2015 to 2017, Mr. Proulx served as Vice President of Engineering at Zonare Medical / Mindray NA, an ultrasound imaging company, and from 2009 to 2015 as Vice President R&D at Sonitus Medical, a medical device company. Mr. Proulx earned a B.S. in Biomedical Engineering from Duke University and an M.S. in Electrical Engineering from Stanford University.
Stacey Ellul has served as our Vice President, Quality & Regulatory Affairs since December 2022. Ms. Ellul previously served as Vice President of Regulatory Science & Communications for the Diabetes Operating Unit of Medtronic, a medical device company, from 2019 to 2022. Since 2003, Ms. Ellul has held positions of increasing responsibility in medical device companies in both regulatory, clinical/ medical affairs, and quality. Prior to joining the medical device industry Ms. Ellul was a critical care nurse. She earned a DipApp Sc (Nursing), GradDip (Management) and an MBA from the University of South Australia, Australia.
Further information can be found on her LinkedIn page. https://www.linkedin.com/in/stacey-ellul-522ab/